| Epigenetic mechanisms as a new approach in cancer treatment: An updated review M Fardi, S Solali, MF Hagh Genes & diseases 5 (4), 304-311, 2018 | 180 | 2018 |
| Toll-like receptors as a key regulator of mesenchymal stem cell function: an up-to-date review S Shirjang, B Mansoori, S Solali, MF Hagh, K Shamsasenjan Cellular Immunology 315, 1-10, 2017 | 103 | 2017 |
| Aberrant miRNA promoter methylation and EMT‐involving miRNAs in breast cancer metastasis: diagnosis and therapeutic implications M Zare, M Bastami, S Solali, MR Alivand Journal of cellular physiology 233 (5), 3729-3744, 2018 | 100 | 2018 |
| The crucial role of ZEB2: from development to epithelial‐to‐mesenchymal transition and cancer complexity M Fardi, M Alivand, B Baradaran, M Farshdousti Hagh, S Solali Journal of cellular physiology 234 (9), 14783-14799, 2019 | 91 | 2019 |
| Down‐regulation of intracellular anti‐apoptotic proteins, particularly c‐FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL A Hassanzadeh, M Farshdousti Hagh, MR Alivand, AAM Akbari, ... Journal of cellular physiology 233 (10), 6470-6485, 2018 | 43 | 2018 |
| Gene expression of TWIST1 and ZBTB16 is regulated by methylation modifications during the osteoblastic differentiation of mesenchymal stem cells F Marofi, G Vahedi, S Solali, M Alivand, S Salarinasab, ... Journal of cellular physiology 234 (5), 6230-6243, 2019 | 42 | 2019 |
| The role of XIAP in resistance to TNF-related apoptosis-inducing ligand (TRAIL) in Leukemia R Saraei, M Soleimani, AAM Akbari, MF Hagh, A Hassanzadeh, S Solali Biomedicine & Pharmacotherapy 107, 1010-1019, 2018 | 39 | 2018 |
| TNF-related apoptosis-inducing ligand (TRAIL) as the potential therapeutic target in hematological malignancies A Naimi, AA Movassaghpour, MF Hagh, M Talebi, A Entezari, ... Biomedicine & Pharmacotherapy 98, 566-576, 2018 | 37 | 2018 |
| Aberrant DNA methylation of key genes and Acute Lymphoblastic Leukemia SS Mina Rahmani, Mehdi Talebi, Majid Farshdousti Hagh, Abbas A.Hosseinpour Feizi Biomedicine & Pharmacotherapy 97, 1493-1500, 2018 | 37 | 2018 |
| Quercetin sensitizes human myeloid leukemia KG‐1 cells against TRAIL‐induced apoptosis A Naimi, A Entezari, MF Hagh, A Hassanzadeh, R Saraei, S Solali Journal of cellular physiology 234 (8), 13233-13241, 2019 | 35 | 2019 |
| Flavonoid-based cancer therapy: an updated review E Hosseinzadeh, A Hassanzadeh, F Marofi, MR Alivand, S Solali Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2020 | 33 | 2020 |
| Novel epigenetic controlling of hypoxia pathway related to overexpression and promoter hypomethylation of TET1 and TET2 in RPE cells MR Alivand, ZS Soheili, M Pornour, S Solali, F Sabouni Journal of cellular biochemistry 118 (10), 3193-3204, 2017 | 31 | 2017 |
| Epigenetic mechanisms are behind the regulation of the key genes associated with the osteoblastic differentiation of the mesenchymal stem cells: The role of zoledronic acid on … F Marofi, A Hassanzadeh, S Solali, G Vahedi, R Mousavi Ardehaie, ... Journal of cellular physiology 234 (9), 15108-15122, 2019 | 28 | 2019 |
| Double sword role of EZH2 in leukemia S Safaei, B Baradaran, MF Hagh, MR Alivand, M Talebi, T Gharibi, ... Biomedicine & Pharmacotherapy 98, 626-635, 2018 | 26 | 2018 |
| Kaempferol improves TRAIL-mediated apoptosis in leukemia MOLT-4 cells by the inhibition of anti-apoptotic proteins and promotion of death receptors expression A Hassanzadeh, A Naimi, MF Hagh, R Saraei, F Marofi, S Solali Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2019 | 20 | 2019 |
| MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers M Sajjadi-Dokht, TAM Mohamad, HS Rahman, MS Maashi, S Danshina, ... Genes & diseases 9 (4), 849-867, 2022 | 16 | 2022 |
| Promoter methylation status of survival-related genes in MOLT-4 cells co-cultured with Bone Marrow Mesenchymal Stem Cells under hypoxic condition MFH Milad Ahani-Nahayati, Saeed Solali, Karim Shams Asanjan, Ali Akbar ... Cell Journal (Yakhteh) 20 (2), 2018 | 16 | 2018 |
| microRNAs involved in T‐cell development, selection, activation, and hemostasis B Emamgolizadeh Gurt Tapeh, B Mosayyebi, M Samei, ... Journal of Cellular Physiology 235 (11), 8461-8471, 2020 | 15 | 2020 |
| Emerging molecular functions of microRNA-124: cancer pathology and therapeutic implications M Moghadasi, M Alivand, M Fardi, KS Moghadam, S Solali Pathology-Research and Practice 216 (3), 152827, 2020 | 15 | 2020 |
| IGF family effects on development, stability, and treatment of hematological malignancies M Moonesi, S Zaka Khosravi, S Molaei Ramshe, ... Journal of Cellular Physiology 236 (6), 4097-4105, 2021 | 14 | 2021 |
